Effect of β3‐adrenoceptor agonist on the micromotion of bilateral major pelvic ganglion‐excised rat bladder
Neurourology and Urodynamics · 2023
DOI: 10.1002/nau.25127 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurourology and Urodynamics, 2023. Verfasst von Hee Seo Son und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology and Urological Science Institute, Yonsei University College of Medicine, Severance Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Urinary Bladder, Urinary Bladder, Overactive. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Aims
Micromotion is an autonomous intramural movement of the bladder, and is believed to be an initial step in the generation of urinary urgency. Therefore, controlling micromotion may be a novel target in overactive bladder (OAB) treatment. However, developing micromotion treatment has been limited by the absence of a standardized animal model. We attempted to create a micromotion animal model and investigated the effectiveness of a β 3 ‐adrenoceptor agonist (CL316,243) on micromotion.
Methods
Bilateral major pelvic ganglia (MPGs) were excised in 18 male Sprague–Dawley rats, resulting in an almost completely denervated bladder. On postoperative Day 7, cystometry was performed. Rats were divided into three treatment groups: CL316,243; β 3‐ adrenoceptor antagonist (SR59230A) pretreated CL316,243; and a nonselective antimuscarinic agent (oxybutynin). Changes in micromotion were evaluated after the intra‐arterial administration of each agent.
Results
Low‐amplitude oscillations in intravesical pressure (micromotion) were observed 1 week after MPGs excision. Micromotion frequency significantly ( p = 0.003) decreased (2.17 ± 3.54 times/5 min) with CL316,243 compared with vehicle (6.33 ± 1.97 times/5 min). Micromotion amplitude also decreased with CL316,243 (1.15 ± 1.93 cmH 2 O) compared with vehicle (5.96 ± 5.12 cmH 2 O), approaching conventional significance ( p = 0.090). No significant decreases in frequency or amplitude were observed with oxybutynin treatment.
Conclusions
Systemic administration of the β 3 ‐adrenoceptor agonist CL316,243 effectively controlled micromotion in bilateral MPGs‐excised, almost completely denervated rat bladders. This result indicates that β 3 ‐adrenoceptor agonist may affect the bladder directly, suggesting that it might be effective for overall OAB, regardless of the presence or level of neurological deficits. Bilateral MPGs‐excised rats are considered a plausible micromotion animal model suitable for future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology and Urological Science Institute, Yonsei University College of Medicine, Severance Hospital, Seoul, Republic of Korea.
- Biomedical Research Center, Korea University Ansan Hospital, Ansan, Republic of Korea.
- Department of Urology, Daegu Fatima Hospital, Daegu, Republic of Korea.
ORCID-Profile: Hee Seo Son, Soo Young Moon, Joonbeom Kwon, Jang Hwan Kim
Zitieren
APA
Son, H. S., Moon, S. Y., Kwon, J., & Kim, J. H. (2023). Effect of β3‐adrenoceptor agonist on the micromotion of bilateral major pelvic ganglion‐excised rat bladder. Neurourology and Urodynamics. https://doi.org/10.1002/nau.25127
Vancouver
Son HS, Moon SY, Kwon J, Kim JH. Effect of β3‐adrenoceptor agonist on the micromotion of bilateral major pelvic ganglion‐excised rat bladder. Neurourology and Urodynamics. 2023. doi:10.1002/nau.25127
BibTeX
@article{Son2023,
author = {Son, Hee Seo and Moon, Soo Young and Kwon, Joonbeom and Kim, Jang Hwan},
title = {Effect of β3‐adrenoceptor agonist on the micromotion of bilateral major pelvic ganglion‐excised rat bladder},
journal = {Neurourology and Urodynamics},
year = {2023},
doi = {10.1002/nau.25127}
}
EUVIMED